Bøker av Sammy Saab

In this issue of Clinics in Liver Disease, guest editor Dr. Sammy Saab brings his considerable expertise to the topic of Hepatic Encephalopathy. Hepatic encephalopathy (HE) is a reversible syndrome in patients with advanced liver dysfunction, and is characterized by a wide spectrum of neuropsychiatric abnormalities resulting from the accumulation of neurotoxic substances in the brain. In this issue, top experts provide detailed clinical reviews devoted to the epidemiology, manifestations, and management of HE in the hopes of improving patient outcomes.Contains 13 relevant, practice-oriented topics including clinical manifestations of HE; laboratory abnormalities of HE; pharmacologic management of HE; nontraditional treatment of HE; social impact of HE; future therapies of HE; and more.Provides in-depth clinical reviews on hepatic encephalopathy, offering actionable insights for clinical practice.Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Patient providers need to continue to stay abreast of the advances in the care of patients with advanced liver disease. They will continue to be exposed to a greater number of patients with cirrhosis, a reflection of the increasing burden of liver disease in patients where non-alcoholic steatohepatitis and even hepatitis C mature to cirrhosis. Although the hepatitis C viral infection can be eliminated, the natural history of the disease will not be necessarily completely altered. For this issue on Portal Hypertension, recognized authorities in these areas stress the relevance, utility, and novelty in their clinical review articles so that they can be used by practicing providers, quoted in the medical literature, and referenced in lectures. Topics addressed are Portal Hypertension, Sarcopenia, Hepatic Encephalopathy, Varices, Ascites and Hepatorenal Syndrome, Pulmonary Complications, Pharmacologic Management, Non-Cirrhotic Portal Hypertension, and Surgery in the Portal Hypertension Patient.